Trial Profile
A randomized controlled study on the treatment of active lupus nephritis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus (Primary) ; Corticosteroids; Cyclophosphamide
- Indications Lupus nephritis
- Focus Therapeutic Use
- 21 May 2012 Planned End Date changed from 1 Dec 2011 to 31 Dec 2014 as reported by Chinese Clinical Trial Register record.
- 21 Jun 2010 New trial record